Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business
  • Functional Area
  • Erscheinungsdatum Sort descending
Positionsbezeichnung Site Standort Division Business Functional Area Erscheinungsdatum Sort descending
Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Deutschland International Innovative Medicines Communications & Public Affairs Jul 09, 2024
Clinical Development Medical Director - Immunology, Rheumatology East Hanover USA Development Innovative Medicines Research & Development Jul 09, 2024
Omnichannel Engagement Manager (m/w/d) Munich (Non-Sales Force) (Novartis Pharma GmbH) Deutschland International Innovative Medicines Marketing Jul 10, 2024
Associate Director Pipeline Management Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 10, 2024
Japan Program Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 10, 2024
Automatisierungsingenieur (m/w/d) Schaftenau Österreich Operations Innovative Medicines Technical Operations Jul 10, 2024
Clinical Data Specialist II Hyderabad (Office) Indien Biomedical Research Research & Development Jul 10, 2024
Clinical Data Specialist I Hyderabad (Office) Indien Biomedical Research Research & Development Jul 10, 2024
Clinical Sciences Trial Leader Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 10, 2024
Lead, RWE and Evidence Excellence Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 10, 2024
Automatiker im Schichtbetrieb Stein Aargau Schweiz Operations Innovative Medicines Technical Operations Jul 11, 2024
Engineer (Project) Puurs Belgien Operations Innovative Medicines Technical Operations Jul 11, 2024
Associate Manager - MS&T Hyderabad (Office) Indien Operations Innovative Medicines Technical Operations Jul 11, 2024
RLT Analytical Product Project Leader (m/f/d) Ivrea Italien International Innovative Medicines Research & Development Jul 11, 2024
RLT Analytical Expert (m/f/d) Ivrea Italien International Innovative Medicines Research & Development Jul 11, 2024
RLT Drug Product Project Lead (m/f/d) Ivrea Italien International Innovative Medicines Research & Development Jul 11, 2024
Techniker (d/w/m) Schaftenau Österreich Operations Innovative Medicines Technical Operations Jul 12, 2024
Cell and Gene Warehouse Specialist East Hanover USA Development Innovative Medicines Technical Operations Jul 12, 2024
Senior MR Wuhan (Hubei Province) China International Innovative Medicines Der Umsatz Jul 12, 2024
Disease Area Specialist Israel Israel International Innovative Medicines Der Umsatz Jul 15, 2024
Sr. Spec. IT Solution Delivery INSURGENTES Mexiko Operations CTS Informationstechnologie Jul 15, 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development Jul 15, 2024
Global Program Clinical Head East Hanover USA Development Innovative Medicines Research & Development Jul 15, 2024
Global Category Manager BT and MCE Governance APAC Hyderabad (Office) Indien Operations CTS Beschaffung Jul 16, 2024
Sr.Specialist – Wireless Network Engineering INSURGENTES Mexiko Operations CTS Technology Transformation Jul 16, 2024
Network Specialist INSURGENTES Mexiko Operations CTS Technology Transformation Jul 16, 2024
Network Specialist INSURGENTES Mexiko Operations CTS Technology Transformation Jul 16, 2024
Specialist – Wireless Network Engineering INSURGENTES Mexiko Operations CTS Technology Transformation Jul 16, 2024
Senior Specialist - Automation Engineer Sasayama Japan Operations Research & Development Jul 16, 2024
高级医药代表 Hechi (Guangxi Province) China International Innovative Medicines Der Umsatz Jul 16, 2024
Private Cloud, Service Delivery Manager Prague Tschechische Republik Operations CTS Technology Transformation Jul 17, 2024
Specialist - Mobile Device Management (MDM) Engineer Prague Tschechische Republik Operations CTS Technology Transformation Jul 17, 2024
ERP Assurance Senior Consultant Selangor Malaysia Operations CTS Audit und Finanzen Jul 17, 2024
Revenue Accounting Manager Shanghai (Shanghai) China Finance CTS Audit und Finanzen Jul 17, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Der Umsatz Jul 18, 2024
Sr Manager/Manager-Monitoring Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compliance Jul 18, 2024
Equipment Qualification Engineer East Hanover USA Development Innovative Medicines Technical Operations Jul 18, 2024
Laboratory Asset Maintenance and Calibration Engineer East Hanover USA Development Innovative Medicines Technical Operations Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Der Umsatz Jul 18, 2024
Associate Sales Manager Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Der Umsatz Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Der Umsatz Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Der Umsatz Jul 18, 2024
Senior Statistical Programmer Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Der Umsatz Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Der Umsatz Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Der Umsatz Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Der Umsatz Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Der Umsatz Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Der Umsatz Jul 18, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Der Umsatz Jul 18, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.